Nyrada will now move on to Phase I clinical trial in humans, which is scheduled for the second half of the 2024 calendar year. so till then nothing but a slide
Ann: Nyrada Commences Walter Reed Traumatic Brain Injury Study, page-148
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
29.8¢ |
Change
-0.003(0.83%) |
Mkt cap ! $62.90M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 30.0¢ | 29.5¢ | $60.58K | 204.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 43214 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 259493 | 4 |
View Market Depth
| Last trade - 15.49pm 11/08/2025 (20 minute delay) ? |
| NYR (ASX) Chart |